Всероссийская GMP-конференция | National Immunobiological Company
National Immunobiological Company

Special partner

127473,  Moscow,
2-nd Volkonsky lane, 10

Тел.: +7 (495) 649 96 30
E-mail: info@nacimbio.ru


National Immunobiological Company or Nacimbio was established on October 29, 2013 with a view to create a holding company of the Rostec State Corporation to develop and produce immunobiological products.

Nacimbio’s mission is to facilitate development of Russian immunobiological enterprises and ensure national sovereignty in the production and supply of immunobiological medicines, which lack of production in the Russian Federation poses a threat to national security in health care.

Nacimbio’s market priorities include development, full-cycle production, and sales of vaccines and anatoxins of the current and future National Preventive Vaccination Schedule; blood-derived products; bacteriophages; allergens and allergoids; immunobiological medicines included in the list of vital and essential medicines.